EEG Monitoring in Children With Moyamoya Disease

NCT ID: NCT03173014

Last Updated: 2017-07-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

10 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-06-30

Study Completion Date

2018-06-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

EEG in moyamoya disease in children preoperatively

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

EEG monitoring in children with moyamoy disease preoperatively for 10 minutes

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

EEG With Periodic Abnormalities

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

EEG

EEG monitoring

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* moyamoya disease

Exclusion Criteria

* refusal
Minimum Eligible Age

5 Years

Maximum Eligible Age

10 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Seoul National University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Hee-Soo Kim

MD, PhD, Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Hee-Soo Kim

Role: PRINCIPAL_INVESTIGATOR

Seoul National University Children's Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hee-Soo Kim

Seoul, Soul-t'ukpyolsi, South Korea

Site Status RECRUITING

Seoul National University Hospital

Seoul, , South Korea

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

South Korea

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Hee-Soo Kim

Role: CONTACT

1052878006

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Hee-Soo Kim

Role: primary

1052878006

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1705-013-851

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Cerebellar Mutism Syndrome Study
NCT02300766 RECRUITING